CINDY EARLE: Open Payments
NPI 1740514728 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,957 in 146 payments from 35 companies in 2025. Trend: 2023 $3,707 · 2024 $3,503 · 2025 $3,957
Food & beverage: $3,957
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $684 |
| Amgen Inc. | 24 | $414 |
| Dexcom, Inc. | 10 | $365 |
| Sequel Med Tech, LLC | 7 | $251 |
| Lilly USA, LLC | 13 | $225 |
| Insulet Corporation | 9 | $213 |
| Corcept Therapeutics | 11 | $198 |
| Ascensia Diabetes Care Us Inc. | 2 | $189 |
| Mannkind Corporation | 7 | $181 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
Products named: Ozempic, Dexcom G6 Transmitter, TWIIST, JARDIANCE, EVENITY, Omnipod, Korlym, AFREZZA.
Industry payments across TN — which companies pay providers there.
